Table 4.
Clinical characteristics of two clusters in the GSE4573 cohort.
| Cluster 1 (n = 79) | Cluster 2 (n = 51) | Statistical value | p value | |
|---|---|---|---|---|
| Age (median [IQR]) | 68 ([59, 75]) | 66 ([61, 75]) | -0.634 | 0.528 |
| Gender (%) | 0.625 | 0.419 | ||
| Female | 27 (34.2) | 21 (41.2) | ||
| Male | 52 (65.8) | 30 (58.8) | ||
| pT stage (%) | 2.498 | 0.114 | ||
| T1-2 | 63 (79.7) | 46 (90.2) | ||
| T3-4 | 16 (20.3) | 5 (9.8) | ||
| pN stage (%) | 4.134 | 0.042∗ | ||
| N0 | 45 (57) | 38 (74.5) | ||
| N1-N3 | 34 (43) | 13 (25.5) | ||
| pTNM stage (%) | 5.591 | 0.018∗ | ||
| I-II | 60 (75.9) | 47 (92.2) | ||
| III-IV | 19 (24.1) | 4 (7.8) |
∗ p < 0.05.